| 000 | 01538 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514002620.0 | ||
| 264 | 0 | _c20011214 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1040-8428 | ||
| 024 | 7 |
_a10.1016/s1040-8428(01)00116-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNewton, D L | |
| 245 | 0 | 0 |
_aSpecifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _c |
||
| 300 |
_a79-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Differentiation, B-Lymphocyte _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aCell Adhesion Molecules |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotoxins _xchemistry |
| 650 | 0 | 4 | _aLectins |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aRNA _xmetabolism |
| 650 | 0 | 4 |
_aRibonucleases _xtherapeutic use |
| 650 | 0 | 4 | _aSialic Acid Binding Ig-like Lectin 2 |
| 700 | 1 | _aHansen, H J | |
| 700 | 1 | _aLiu, H | |
| 700 | 1 | _aRuby, D | |
| 700 | 1 | _aIordanov, M S | |
| 700 | 1 | _aMagun, B E | |
| 700 | 1 | _aGoldenberg, D M | |
| 700 | 1 | _aRybak, S M | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 39 _gno. 1-2 _gp. 79-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1040-8428(01)00116-0 _zAvailable from publisher's website |
| 999 |
_c11348076 _d11348076 |
||